Antiretroviral treatment in the private sector in Namibia

International Journal of STD and AIDS

Volumn 22, Issue 10, 2011, Pages 577-580

  van der Veen, F ^a,b   Mugala Mukungu, F ^a   Kangudi, M ^a   Feris, A ^a   Katjitae, I ^c   Colebunders, R ^b,d  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Windhoek Central Hospital   (Namibia)

^c Ministry of Health   (Namibia)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Africa; Antiretroviral therapy; Coverage; Guideline; HIV; Resource limited settings

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; STAVUDINE;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; DRUG EFFICACY; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMIBIA; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REIMBURSEMENT;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; FEMALE; GUIDELINE ADHERENCE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; NAMIBIA; PRACTICE GUIDELINES AS TOPIC; PRIVATE SECTOR; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 80054728039     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2011.010452     Document Type: Article

References (24)

1. Wilson B. The private sector response to AIDS in Botswana. Lancet 2007;7:766
2. De Beers Group. A focus on HIV/Aids Management HIV/AIDS Case Study 2006. See http://www.gbcimpact.org/files/transfers/HIV-AIDS%20brochure.pdf (last checked 28 April 2010)
3. De Beers Report to Society 2008. See http://www.debeersgroup.com/ImageVault/Images/id_1847/ImageVaultHandler.aspx (last checked 28 April 2010)
4. Gething L, Fourie B. DaimlerChrysler SA HIV/AIDS Workplace Project 2001-2003, Final Evaluation September/October 2003. See http-//www.daimlerchrysler.co.za/social/aids/Pdf_file%5CDCSA%20HIV-AIDS%20Workplace%20Project%20 Final%20Report%202003.pdf (last checked 28 April 2010)
5. Janssens V, van der Borght S. ARV-Procurement: Experiences in the Heineken HAART Project. 15th International Conference on AIDS. 11-16 July 2004; 15: abstract no. WePeE6827. See http://gateway.nlm.nih.gov/MeetingAbstracts/ ma?f=102284738.html (last checked 5 May 2010)
6. Mahajan AP, Colvin M, Rudatsikira JB, Ettl D. An overview of HIV/AIDS workplace policies and programmes in Southern Africa. AIDS 2007;21(Suppl. 3):S31-S39
7. Staff writer. Engaging the private sector in global health. Lancet Infect Dis 2007;7:757
8. Badri M, Maartens G, Mandalia S, et al. Cost-effectiveness of highly active antiretroviral therapy in South Africa. PLoS Med 2006;3:48-56
9. Dentliger L. Report on the National Assembly meeting of 1 March 2005 on the Public Service Employees Medical Aid Scheme by the Minister of Finance, Sara Kuukongelwa-Amadhila. The Namibian, 2 March 2005
10. Janssens W, Gustafsson-Wright A. A Unique Low-cost Private Health Insurance Program in Namibia: Protection from Health Shocks including HIV/AIDS. Rotterdam: Institute of Social Studies, 2008. See http://www.iss.nl/DevISSues/Articles/A-Unique-Low-Cost-Private-Health-Insurance-Program-in-Namibia-Protection-from-Health-Shocks-Including-HIV-AIDS (last checked 27 September 2011)
11. World Health Organization. Scaling-up Antiretroviral Therapy in Resource-Limited Settings. Geneva: WHO, 2003
12. Gilks CF, Crowley S, Ekpini R, et al. The WHO public health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2004;368:505-10
13. Schwartzlander B, Stover J, Walker N, et al. Resource needs for HIV/AIDS. Science 2001;292:2434-36
14. Republic of Namibia. Ministry of Health and Social Services. Guidelines for Anti-Retroviral Treatment. Directorate of Primary Health Care: Windhoek, 2003
15. Van der Veen F, Aziz E, Kangudie M. Monitoring key indicators for the achievement of PMTCT and ART development goals at district level in Namibia. Poster presentation AIDS-XVI International AIDS Conference, 2006 Abstract MOPE0709
16. De Beer M, Coutinho MF, Van Wyk PJ, et al. Anonymous HIV workplace surveys as an advocacy tool for affordable private health insurance in Namibia. J Int AIDS Soc 2009;12:32. See http://www.jiasociety.org/content/12/1/32/ (last checked 5 May 2010)
17. UNAIDS 2008 report on the global AIDS epidemic. See http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/2008_Global_report.asp (last checked 2 May 2010)
18. WHO UNIADS UNICEF. Towards Universal Access. See http://www.who.int/hiv/pub/tuapr_2009_en.pdf page(last checked 27 September 2011)
19. Musavi A. Namibia saving positive babies. IRIN PluSNews, 3 August 2009.
20. Ivers LC, Kendrick D. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis 2005;41:217-24
21. Ramiah I, Reich MR. Building effective public-private partnerships: experiences and lessons from the African Comprehensive HIV/AIDS Partnerships (ACHAP). Soc Sci Med 2006;63:397-408
22. Gregory P, Bisson GP, Ian Frank I, et al. Out-of-pocket costs of HAART limit HIV treatment responses in Botswanás private sector. AIDS 2006;9:1333-36
23. Macharia D, Chang K, Larry W, et al. Antiretroviral therapy in the private sector of Nairobi, Kenya: a review of the experience of five physicians. AIDS 2003;17:938-40
24. Hong SY, Jonas A, Dumeni E, et al. Population-based monitoring of HIV drug resistance in Namibia with early warning indicators. J Acquir Immune Defic Syndr 2010;55:e27-31